Business
“Reality check”: In early data, AstraZeneca vaccine offers minimal protection against South African variant – Sydney Morning Herald
Australian health authorities have backed AstraZeneca’s vaccine despite South Africa’s decision to pause roll-out of the jab, after early clinical data showed it…
It remains unclear if the vaccine will still protect against serious illness and death; scientists who were part of the South African trial are hopeful it will.
The University of Oxford, which co-developed the vaccine, said it was working on a booster jab to provide protection against the variant, if necessary.
CSL, which is contracted by the government and AstraZeneca to produce 50 million doses of the vaccine at its Broadmeadows plant, did not comment directly on whether it could modify the jab…
-
General13 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
General22 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General20 hours agoWarner Bros Discovery board rejects rival $163bn bid from Paramount
-
Noosa News13 hours agoE-Scooter accident | Noosa Today